BLUEROCK HOMES TRUST INC (BHM) Fundamental Analysis & Valuation

NYSEARCA:BHM • US09631H1005

Current stock price

10.51 USD
-0.09 (-0.85%)
Last:

This BHM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. BHM Profitability Analysis

1.1 Basic Checks

  • BHM had negative earnings in the past year.
  • In the past year BHM had a positive cash flow from operations.
  • In the past 5 years BHM reported 4 times negative net income.
  • In the past 5 years BHM always reported a positive cash flow from operatings.
BHM Yearly Net Income VS EBIT VS OCF VS FCFBHM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

  • BHM's Return On Assets of -1.02% is on the low side compared to the rest of the industry. BHM is outperformed by 75.00% of its industry peers.
  • BHM has a worse Return On Equity (-4.14%) than 75.00% of its industry peers.
Industry RankSector Rank
ROA -1.02%
ROE -4.14%
ROIC N/A
ROA(3y)-0.42%
ROA(5y)2.73%
ROE(3y)-1.76%
ROE(5y)1.52%
ROIC(3y)N/A
ROIC(5y)N/A
BHM Yearly ROA, ROE, ROICBHM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

  • With a Gross Margin value of 42.61%, BHM is not doing good in the industry: 95.00% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of BHM has declined.
  • The Profit Margin and Operating Margin are not available for BHM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.92%
GM growth 5YN/A
BHM Yearly Profit, Operating, Gross MarginsBHM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 200 -200 400 600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. BHM Health Analysis

2.1 Basic Checks

  • BHM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, BHM has more shares outstanding
  • BHM has a worse debt/assets ratio than last year.
BHM Yearly Shares OutstandingBHM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M
BHM Yearly Total Debt VS Total AssetsBHM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of 0.20, we must say that BHM is in the distress zone and has some risk of bankruptcy.
  • BHM has a worse Altman-Z score (0.20) than 80.00% of its industry peers.
  • BHM has a Debt/Equity ratio of 1.55. This is a high value indicating a heavy dependency on external financing.
  • BHM has a worse Debt to Equity ratio (1.55) than 65.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF N/A
Altman-Z 0.2
ROIC/WACCN/A
WACC5.09%
BHM Yearly LT Debt VS Equity VS FCFBHM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

  • A Current Ratio of 5.01 indicates that BHM has no problem at all paying its short term obligations.
  • The Current ratio of BHM (5.01) is better than 100.00% of its industry peers.
  • A Quick Ratio of 5.01 indicates that BHM has no problem at all paying its short term obligations.
  • The Quick ratio of BHM (5.01) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 5.01
Quick Ratio 5.01
BHM Yearly Current Assets VS Current LiabilitesBHM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. BHM Growth Analysis

3.1 Past

  • BHM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -234.65%.
  • BHM shows a strong growth in Revenue. In the last year, the Revenue has grown by 35.66%.
  • Measured over the past years, BHM shows a very strong growth in Revenue. The Revenue has been growing by 50.84% on average per year.
EPS 1Y (TTM)-234.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-489.07%
Revenue 1Y (TTM)35.66%
Revenue growth 3Y50.84%
Revenue growth 5YN/A
Sales Q2Q%30.73%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BHM Yearly Revenue VS EstimatesBHM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

Find the best growth stocksShow best growing peers

0

4. BHM Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BHM. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BHM Price Earnings VS Forward Price EarningsBHM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BHM is valued expensively inside the industry as 95.00% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 37.97
BHM Per share dataBHM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. BHM Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 7.08%, BHM is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 46.06, BHM pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.91, BHM pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.08%

5.2 History

  • BHM is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BHM Yearly Dividends per shareBHM Yearly Dividends per shareYearly Dividends per share 2023 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • The earnings of BHM are negative and hence is the payout ratio. BHM will probably not be able to sustain this dividend level.
DP-82.78%
EPS Next 2YN/A
EPS Next 3YN/A
BHM Yearly Income VS Free CF VS DividendBHM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 100M -100M -200M

More info and screens

Find the best dividend stocksShow peers with best dividend

BHM Fundamentals: All Metrics, Ratios and Statistics

BLUEROCK HOMES TRUST INC

NYSEARCA:BHM (3/13/2026, 8:11:34 PM)

10.51

-0.09 (-0.85%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)11-06
Earnings (Next)N/A
Inst Owners35.92%
Inst Owner ChangeN/A
Ins Owners9.18%
Ins Owner Change0%
Market Cap42.67M
Revenue(TTM)63.63M
Net Income(TTM)-11.12M
Analysts84
Price Target11.22 (6.76%)
Short Float %0.43%
Short Ratio1.64
Dividend
Industry RankSector Rank
Dividend Yield 7.08%
Yearly Dividend1.87
Dividend Growth(5Y)N/A
DP-82.78%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.67
P/FCF N/A
P/OCF 1.28
P/B 0.16
P/tB 0.16
EV/EBITDA 37.97
EPS(TTM)-2.87
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-82.83
FCFYN/A
OCF(TTM)8.19
OCFY77.94%
SpS15.67
BVpS66.17
TBVpS65.72
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.02%
ROE -4.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.61%
FCFM N/A
ROA(3y)-0.42%
ROA(5y)2.73%
ROE(3y)-1.76%
ROE(5y)1.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.92%
GM growth 5YN/A
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF N/A
Debt/EBITDA 53.32
Cap/Depr 1233.63%
Cap/Sales 580.74%
Interest Coverage N/A
Cash Conversion 426.88%
Profit Quality N/A
Current Ratio 5.01
Quick Ratio 5.01
Altman-Z 0.2
F-Score3
WACC5.09%
ROIC/WACCN/A
Cap/Depr(3y)728.9%
Cap/Depr(5y)962.54%
Cap/Sales(3y)349.98%
Cap/Sales(5y)565.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-234.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-489.07%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)35.66%
Revenue growth 3Y50.84%
Revenue growth 5YN/A
Sales Q2Q%30.73%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-30.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1802.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14560%
OCF growth 3Y-2.62%
OCF growth 5YN/A

BLUEROCK HOMES TRUST INC / BHM Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BLUEROCK HOMES TRUST INC?

ChartMill assigns a fundamental rating of 2 / 10 to BHM.


Can you provide the valuation status for BLUEROCK HOMES TRUST INC?

ChartMill assigns a valuation rating of 0 / 10 to BLUEROCK HOMES TRUST INC (BHM). This can be considered as Overvalued.


How profitable is BLUEROCK HOMES TRUST INC (BHM) stock?

BLUEROCK HOMES TRUST INC (BHM) has a profitability rating of 1 / 10.


Can you provide the financial health for BHM stock?

The financial health rating of BLUEROCK HOMES TRUST INC (BHM) is 3 / 10.